Publications

  1. Moreno-Luna LE, Yang JD, Sanchez W, Paz-Fumagalli R, Harnois DM, Mettler TA, Gansen DN, de Groen PC, Lazaridis KN, Narayanan Menon KV, Larusso NF, Alberts SR, Gores GJ, Fleming CJ, Slettedahl SW, Harmsen WS, Therneau TM, Wiseman GA, Andrews JC, Roberts Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2013 Jun; 36(3):714-23. Epub 2012 Oct 24. 2279057
    View PubMed
  2. Melton LJ 3rd, Achenbach SJ, Atkinson EJ, Therneau TM, Amin S. Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos Int. 2013 May; 24(5):1689-96. Epub 2012 Dec 05. 2288193
    View PubMed
  3. McCoy SS, Crowson CS, Maradit-Kremers H, Therneau TM, Roger VL, Matteson EL, Gabriel SE. Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol. 2013 May; 40(5):605-10. Epub 2013 Feb 15. 2304034
    View PubMed
  4. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation of Liver-Related Mortality in the United States. Gastroenterology. 2013 Apr 09. [Epub ahead of print] 2316574
    View PubMed
  5. Myasoedova E, Davis JM, Crowson CS, Roger VL, Karon BL, Borgeson DD, Therneau TM, Matteson EL, Rodeheffer RJ, Gabriel SE. Rheumatoid arthritis is associated with left ventricular concentric remodeling: Results of a population-based cross-sectional study. Arthritis Rheum. 2013 Apr 01. [Epub ahead of print] 2314579
    View PubMed
  6. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013 Apr; 57(4):1357-65. Epub 2013 Jan 25. 2285344
    View PubMed
  7. Kyle RA, Therneau TM, Dispenzieri A, Kumar S, Benson JT, Larson DR, Melton LJ 3rd, Rajkumar SV. Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):184-6. Epub 2013 Mar 13. 2311150
    View PubMed
  8. Carballido-Gamio J, Harnish R, Saeed I, Streeper T, Sigurdsson S, Amin S, Atkinson EJ, Therneau TM, Siggeirsdottir K, Cheng X, Melton LJ 3rd, Keyak J, Gudnason V, Khosla S, Harris TB, Lang TF. Proximal femoral density distribution and structure in relation to age and hip fracture risk in women. J Bone Miner Res. 2013 Mar; 28(3):537-46. 2307501
    View PubMed
  9. Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, Kim WR, Gores GJ, Roberts RO, Olson JE, Therneau TM, Roberts LR. Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology. 2013 Feb; 57(2):648-55. Epub 2012 Dec 12. 2276832
    View PubMed
  10. Katzmann JA, Clark R, Kyle RA, Larson DR, Therneau TM, Melton LJ 3rd, Benson JT, Colby CL, Dispenzieri A, Landgren O, Kumar S, Bradwell AR, Cerhan JR, Rajkumar SV. Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS. Leukemia. 2013 Jan; 27(1):208-12. Epub 2012 Jul 11. 2257035
    View PubMed
  11. Mahoney DW, Therneau TM, Anderson SK, Jen J, Kocher JP, Reinholz MM, Perez EA, Eckel-Passow JE. Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples. BMC Res Notes. 2013; 6:33. Epub 2013 Jan 30. 2317220
    View PubMed
  12. Therneau TM, Kyle RA, Melton LJ 3rd, Larson DR, Benson JT, Colby CL, Dispenzieri A, Kumar S, Katzmann JA, Cerhan JR, Rajkumar SV. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. Mayo Clin Proc. 2012 Nov; 87(11):1071-9. Epub 2012 Aug 07. 2263966
    View PubMed
  13. Huebner M, Therneau T, Larson D. Estimating underreported N2 disease in rectal cancer patients with low lymph node counts. J Surg Oncol. 2012 Sep 1; 106(3):248-53. Epub 2011 Dec 01. 2208549
    View PubMed
  14. Darwish Murad S, Kim WR, Therneau T, Gores GJ, Rosen CB, Martenson JA, Alberts SR, Heimbach JK. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology. 2012 Sep; 56(3):972-81. Epub 2012 Jul 17. 2295682
    View PubMed
  15. Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol. 2012 Aug 1; 110(3):420-4. Epub 2012 Apr 20. 2240740
    View PubMed
  16. Yang JD, Kim B, Sanderson SO, Sauver JS, Yawn BP, Larson JJ, Therneau TM, Roberts LR, Gores GJ, Kim WR. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008. Am J Gastroenterol. 2012 Aug; 107(8):1256-62. Epub 2012 Jul 03. 2256091
    View PubMed
  17. Yang JD, Kim WR, Park KW, Chaiteerakij R, Kim B, Sanderson SO, Larson JJ, Pedersen RA, Therneau TM, Gores GJ, Roberts LR, Park JW. Model to estimate survival in ambulatory patients with hepatocellular carcinoma. Hepatology. 2012 Aug; 56(2):614-21. Epub 2012 Jul 02. 2256161
    View PubMed
  18. Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W, Kim YJ, Yoon JH, Jeong SH, Lee DH, Lee HS, Larson J, Therneau TM, Kim WR. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012 Aug; 56(2):605-13. Epub 2012 Jul 02. 2267603
    View PubMed
  19. Cheville AL, Yost KJ, Larson DR, Dos Santos K, O'Byrne MM, Chang MT, Therneau TM, Diehn FE, Yang P. Performance of an item response theory-based computer adaptive test in identifying functional decline. Arch Phys Med Rehabil. 2012 Jul; 93(7):1153-60. Epub 2012 Feb 25. 2266938
    View PubMed
  20. Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Therneau TM, Colby CL, Clark RJ, Mead GP, Kumar S, Melton LJ 3rd, Rajkumar SV. Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population. Mayo Clin Proc. 2012 Jun; 87(6):517-23. 2252594
    View PubMed
  21. Kyle RA, Benson JT, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Melton LJ 3rd, Rajkumar SV. Progression in smoldering Waldenstrom macroglobulinemia: long-term results. Blood. 2012 May 10; 119(19):4462-6. Epub 2012 Mar 26. 2235355
    View PubMed
  22. Greenberg AJ, Rajkumar SV, Larson DR, Dispenzieri A, Therneau TM, Colby CL, Phelps TK, Kumar SK, Katzmann JA, Kyle RA, Slager SL, Vachon CM. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma. Br J Haematol. 2012 May; 157(4):472-5. 2242623
    View PubMed
  23. Hartung T, Zhang L, Kanwar R, Khrebtukova I, Reinhardt M, Wang C, Therneau TM, Banck MS, Schroth GP, Beutler AS. Diametrically opposite methylome-transcriptome relationships in high- and low-CpG promoter genes in postmitotic neural rat tissue. Epigenetics. 2012 May; 7(5):421-8. Epub 2012 May 01. 2235268
    View PubMed
  24. Huebner M, Kendrick M, Reid-Lombardo KM, Que F, Therneau T, Qin R, Donohue J, Nagorney D, Farnell M, Sarr M. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg. 2012 May; 16(5):920-6. Epub 2012 Mar 16. 2235256
    View PubMed
  25. Melton LJ 3rd, Hartmann LC, Achenbach SJ, Atkinson EJ, Therneau TM, Khosla S. Fracture risk in women with breast cancer: a population-based study. J Bone Miner Res. 2012 May; 27(5):1196-205. 2218026
    View PubMed
  26. Atkinson EJ, Therneau TM, Melton LJ 3rd, Camp JJ, Achenbach SJ, Amin S, Khosla S. Assessing fracture risk using gradient boosting machine (GBM) models. J Bone Miner Res. 2012 Feb 24. [Epub ahead of print] 2227709
    View PubMed
  27. Shire AM, Sandhu DS, Kaiya JK, Oseini AM, Yang JD, Chaiteerakij R, Mettler TA, Giama NH, Roberts RO, Therneau TM, Petersen GM, Knutson KL, Roberts LR. Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma. Mayo Clin Proc. 2012 Jan; 87(1):17-24. 2215190
    View PubMed
  28. Yang JD, Kim B, Sanderson SO, St Sauver JL, Yawn BP, Pedersen RA, Larson JJ, Therneau TM, Roberts LR, Kim WR. Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008. Mayo Clin Proc. 2012 Jan; 87(1):9-16. 2215203
    View PubMed
  29. Oberg AL, Bot BM, Grill DE, Poland GA, Therneau TM. Technical and biological variance structure in mRNA-Seq data: life in the real world. BMC Genomics. 2012; 13:304. Epub 2012 Jul 07. 2285803
    View PubMed
  30. Schulze SK, Kanwar R, Golzenleuchter M, Therneau TM, Beutler AS. SERE: single-parameter quality control and sample comparison for RNA-Seq. BMC Genomics. 2012; 13:524. Epub 2012 Oct 03. 2292658
    View PubMed
  31. Davis JM 3rd, Knutson KL, Skinner JA, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis. Arthritis Res Ther. 2012; 14(1):R24. Epub 2012 Jan 31. 2221053
    View PubMed
  32. Melton LJ 3rd, Atkinson EJ, Achenbach SJ, Kanis JA, Therneau TM, Johansson H, Khosla S, Amin S. Potential Extensions of the US FRAX Algorithm. J Osteoporos. 2012; 2012:528790. Epub 2012 Aug 15. 2268007
    View PubMed
  33. Al-Khalidi HR, Hong Y, Fleming TR, Therneau TM. Insights on the robust variance estimator under recurrent-events model. Biometrics. 2011 Dec; 67(4):1564-72. Epub 2011 Mar 18. 2155629
    View PubMed
  34. Katzmann JA, Snyder MR, Rajkumar SV, Kyle RA, Therneau TM, Benson JT, Dispenzieri A. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Clin Chem. 2011 Dec; 57(12):1687-92. Epub 2011 Oct 06. 2216573
    View PubMed
  35. Krause ML, Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis. Clin Immunol. 2011 Oct; 141(1):67-72. Epub 2011 May 30. 2172243
    View PubMed
  36. Mahoney DW, Therneau TM, Heppelmann CJ, Higgins L, Benson LM, Zenka RM, Jagtap P, Nelsestuen GL, Bergen HR, Oberg AL. Relative quantification: characterization of bias, variability and fold changes in mass spectrometry data from iTRAQ-labeled peptides. J Proteome Res. 2011 Sep 2; 10(9):4325-33. Epub 2011 Aug 02. 2180616
    View PubMed
  37. Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, Aderca I, Mettler TA, Therneau TM, Zhang L, Takahashi N, Chari ST, Roberts LR. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology. 2011 Sep 2; 54(3):940-8. Epub 2011 Aug 08. 2169980
    View PubMed
  38. Melton LJ 3rd, Lieber MM, Atkinson EJ, Achenbach SJ, Zincke H, Therneau TM, Khosla S. Fracture risk in men with prostate cancer: a population-based study. J Bone Miner Res. 2011 Aug; 26(8):1808-15. 2162130
    View PubMed
  39. Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL, Therneau TM, Gabriel SE. The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol. 2011 Aug; 38(8):1601-6. Epub 2011 May 15. 2165239
    View PubMed
  40. Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, Therneau TM, Orsini L, Kim WR, Roberts LR. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol. 2011 Jul; 9(7):617-23.e1. Epub 2011 Apr 01. 2163940
    View PubMed
  41. Amin S, Kopperdhal DL, Melton LJ 3rd, Achenbach SJ, Therneau TM, Riggs BL, Keaveny TM, Khosla S. Association of hip strength estimates by finite-element analysis with fractures in women and men. J Bone Miner Res. 2011 Jul; 26(7):1593-600. 2147448
    View PubMed
  42. Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Roger VL, Matteson EL, Gabriel SE. A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis. Arthritis Rheum. 2011 Jun; 63(6):1497-506. 2151730
    View PubMed
  43. Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011 Jun; 140(7):1952-60. Epub 2011 Feb 18. 2148627
    View PubMed
  44. Crowson CS, Myasoedova E, Davis JM 3rd, Roger VL, Karon BL, Borgeson D, Rodeheffer RJ, Therneau TM, Gabriel SE. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken). 2011 May; 63(5):729-34. 2170543
    View PubMed
  45. Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011 Mar; 70(3):482-7. Epub 2011 Jan 07. 2141677
    View PubMed
  46. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011 Mar; 63(3):633-9. 2151581
    View PubMed
  47. Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenstrom's macroglobulinemia (SWM). Clin Lymphoma Myeloma Leuk. 2011 Feb; 11(1):74-6. 2165344
    View PubMed
  48. Crowson CS, Myasoedova E, Davis JM 3rd, Matteson EL, Roger VL, Therneau TM, Fitz-Gibbon P, Rodeheffer RJ, Gabriel SE. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol. 2011 Jan; 38(1):29-35. Epub 2010 Oct 15. 2121208
    View PubMed
  49. Yang JD, Kim WR, Coelho R, Mettler TA, Benson JT, Sanderson SO, Therneau TM, Kim B, Roberts LR. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011 Jan; 9(1):64-70. Epub 2010 Sep 08. 2165298
    View PubMed
  50. Chen M, Therneau T, Orsini LS, Qiao YL. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma. BMC Gastroenterol. 2011; 11:53. Epub 2011 May 12. 2173840
    View PubMed
  51. Krause ML, Davis JM, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Corrigendum to "Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis" [Clin. Immunol. 141 (2011) 67-72]. Clin Immunol. 2011; 141(3):372. 2211492
  52. Sun Z, Chai HS, Wu Y, White WM, Donkena KV, Klein CJ, Garovic VD, Therneau TM, Kocher JP. Batch effect correction for genome-wide methylation data with Illumina Infinium platform. BMC Med Genomics. 2011; 4:84. Epub 2011 Dec 16. 2219788
    View PubMed
  53. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2010 Dec 28. [Epub ahead of print] 2136121
    View PubMed
  54. Kim HJ, Larson JJ, Lim YS, Kim WR, Pedersen RA, Therneau TM, Rosen CB. Impact of MELD on waitlist outcome of retransplant candidates. Am J Transplant. 2010 Dec; 10(12):2652-7. Epub 2010 Nov 10. 2124182
    View PubMed
  55. Therneau T. Working with a gold-plated standard. Hepatology. 2010 Nov; 52(5):1527. 2124147
    View PubMed
  56. Bower JH, Grossardt BR, Maraganore DM, Ahlskog JE, Colligan RC, Geda YE, Therneau TM, Rocca WA. Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord. 2010 Oct 15; 25(13):2105-13. 2109315
    View PubMed
  57. Bianchi G, Kyle RA, Colby CL, Larson DR, Kumar S, Katzmann JA, Dispenzieri A, Therneau TM, Cerhan JR, Melton LJ 3rd, Rajkumar SV. Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications. Blood. 2010 Sep 23; 116(12):2019-25; quiz 2197. Epub 2010 May 21. 2002088
    View PubMed
  58. Asrani SK, Kim WR, Pedersen RA, Charlton MR, Kremers WK, Therneau TM, Rosen CB, Dean PG. Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther. 2010 Sep; 32(6):776-86. Epub 2010 Jul 26. 2109347
    View PubMed
  59. Bambha K, Kim WR, Rosen CB, Pedersen RA, Rys C, Kolbert CP, Cunningham JM, Therneau TM. Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant. Mayo Clin Proc. 2010 Sep; 85(9):814-20. 2116236
    View PubMed
  60. Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL, Karon BL, Borgeson DD, Therneau TM, Rodeheffer RJ, Gabriel SE. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis. 2010 Sep; 69(9):1665-70. Epub 2010 May 24. 2112354
    View PubMed
  61. Melton LJ 3rd, Riggs BL, Keaveny TM, Achenbach SJ, Kopperdahl D, Camp JJ, Rouleau PA, Amin S, Atkinson EJ, Robb RA, Therneau TM, Khosla S. Relation of vertebral deformities to bone density, structure, and strength. J Bone Miner Res. 2010 Sep; 25(9):1922-30. 2115603
    View PubMed
  62. Adams LA, Harmsen S, St Sauver JL, Charatcharoenwitthaya P, Enders FB, Therneau T, Angulo P. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol. 2010 Jul; 105(7):1567-73. Epub 2010 Feb 09. 2109448
    View PubMed
  63. Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis. 2010 Jul; 69(7):1310-4. Epub 2009 Oct 23. 2002214
    View PubMed
  64. Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol. 2010 Jun 15; 184(12):7297-304. Epub 2010 May 21. 2101976
    View PubMed
  65. Tang H, Therneau TM. Statistical metrics for quality assessment of high-density tiling array data. Biometrics. 2010 Jun; 66(2):630-5. Epub 2009 Jul 23. 1956987
    View PubMed
  66. Asrani SK, Lim YS, Therneau TM, Pedersen RA, Heimbach J, Kim WR. Donor race does not predict graft failure after liver transplantation. Gastroenterology. 2010 Jun; 138(7):2341-7. Epub 2010 Feb 19. 1987759
    View PubMed
  67. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010 Jun; 62(6):1576-82. 1988604
    View PubMed
  68. Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ 3rd, Colby CL, Therneau TM, Clark R, Kumar SK, Bradwell A, Fonseca R, Jelinek DF, Rajkumar SV. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet. 2010 May 15; 375(9727):1721-8. 2002156
    View PubMed
  69. Lim YS, Larson TS, Benson JT, Kamath PS, Kremers WK, Therneau TM, Kim WR. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol. 2010 Apr; 52(4):523-8. Epub 2010 Feb 04. 1988631
    View PubMed
  70. Crowson CS, Liang KP, Therneau TM, Kremers HM, Gabriel SE. Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis? Arthritis Rheum. 2010 Feb; 62(2):378-82. 1983134
    View PubMed
  71. Berbari EF, Osmon DR, Carr A, Hanssen AD, Baddour LM, Greene D, Kupp LI, Baughan LW, Harmsen WS, Mandrekar JN, Therneau TM, Steckelberg JM, Virk A, Wilson WR. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010 Jan 1; 50(1):8-16. 1974038
    View PubMed
  72. Chai HS, Therneau TM, Bailey KR, Kocher JP. Spatial normalization improves the quality of genotype calling for Affymetrix SNP 6.0 arrays. BMC Bioinformatics. 2010; 11:356. Epub 2010 Jun 29. 2106789
    View PubMed
  73. Eckel-Passow JE, Mahoney DW, Oberg AL, Zenka RM, Johnson KL, Nair KS, Kudva YC, Bergen HR III, Therneau TM. Bi-linear regression for 18O quantification: Modeling across the elution profile. Journal of Proteomics and Bioinformatics. 2010; 3(12):323-9. 2147841
  74. Kim WR, Terrault NA, Pedersen RA, Therneau TM, Edwards E, Hindman AA, Brosgart CL. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology. 2009 Nov; 137(5):1680-6. Epub 2009 Jul 24. 1954822
    View PubMed
  75. Liang KP, Kremers HM, Crowson CS, Snyder MR, Therneau TM, Roger VL, Gabriel SE. Autoantibodies and the risk of cardiovascular events. J Rheumatol. 2009 Nov; 36(11):2462-9. Epub 2009 Oct 15. 1969707
    View PubMed
  76. Dunlay SM, Redfield MM, Weston SA, Therneau TM, Hall Long K, Shah ND, Roger VL. Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol. 2009 Oct 27; 54(18):1695-702. 1969651
    View PubMed
  77. Bida JP, Kyle RA, Therneau TM, Melton LJ 3rd, Plevak MF, Larson DR, Dispenzieri A, Katzmann JA, Rajkumar SV. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc. 2009 Aug; 84(8):685-93. 1956977
    View PubMed
  78. Vachon CM, Kyle RA, Therneau TM, Foreman BJ, Larson DR, Colby CL, Phelps TK, Dispenzieri A, Kumar SK, Katzmann JA, Rajkumar SV. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood. 2009 Jul 23; 114(4):785-90. Epub 2009 Jan 29. 1920506
    View PubMed
  79. Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Reply. Arthritis Rheum. 2009 Jul; 60(7):2206-7. 1950993
    View PubMed
  80. Eckel-Passow JE, Oberg AL, Therneau TM, Bergen HR 3rd. An insight into high-resolution mass-spectrometry data. Biostatistics. 2009 Jul; 10(3):481-500. Epub 2009 Mar 26. 1933655
    View PubMed
  81. Yun BC, Kim WR, Benson JT, Biggins SW, Therneau TM, Kremers WK, Rosen CB, Klintmalm GB. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology. 2009 May; 49(5):1610-5. 1939153
    View PubMed
  82. Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL. Secular trends in hip fracture incidence and recurrence. Osteoporos Int. 2009 May; 20(5):687-94. Epub 2008 Sep 17. 1909082
    View PubMed
  83. Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton Iii LJ, Rajkumar SV. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenstrom's macroglobulinemia. Clin Lymphoma Myeloma. 2009 Mar; 9(1):17-8. 2109209
    View PubMed
  84. Icen M, Nicola PJ, Maradit-Kremers H, Crowson CS, Therneau TM, Matteson EL, Gabriel SE. Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol. 2009 Jan; 36(1):50-7. 1915381
    View PubMed
  85. Asmann YW, Klee EW, Thompson EA, Perez EA, Middha S, Oberg AL, Therneau TM, Smith DI, Poland GA, Wieben ED, Kocher JP. 3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics. 2009; 10:531. Epub 2009 Nov 16. 1974160
    View PubMed
  86. Wettstein P, Strausbauch M, Therneau T, Borson N. The application of real-time PCR to the analysis of T cell repertoires. Nucleic Acids Res. 2008 Dec; 36(21):e140. Epub 2008 Oct 03. 1915571
    View PubMed
  87. Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA. 2008 Nov 5; 300(17):2022-9. 1955077
    View PubMed
  88. Snozek CL, Katzmann JA, Kyle RA, Dispenzieri A, Larson DR, Therneau TM, Melton LJ 3rd, Kumar S, Greipp PR, Clark RJ, Rajkumar SV. Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system. Leukemia. 2008 Oct; 22(10):1933-7. Epub 2008 Jul 03. 1906549
    View PubMed
  89. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4; 359(10):1018-26. 1898698
    View PubMed
  90. Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008 Sep; 58(9):2603-11. 1931432
    View PubMed
  91. Cheville JC, Karnes RJ, Therneau TM, Kosari F, Munz JM, Tillmans L, Basal E, Rangel LJ, Bergstralh E, Kovtun IV, Savci-Heijink CD, Klee EW, Vasmatzis G. Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. J Clin Oncol. 2008 Aug 20; 26(24):3930-6. 1894810
    View PubMed
  92. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum. 2008 Aug; 58(8):2268-74. 1966444
    View PubMed
  93. Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res. 2008 Aug; 23(8):1334-42. 1902515
    View PubMed
  94. Hill EG, Schwacke JH, Comte-Walters S, Slate EH, Oberg AL, Eckel-Passow JE, Therneau TM, Schey KL. A statistical model for iTRAQ data analysis. J Proteome Res. 2008 Aug; 7(8):3091-101. Epub 2008 Jun 26. 1876215
    View PubMed
  95. Gonzalez A, Icen M, Kremers HM, Crowson CS, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE. Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol. 2008 Jun; 35(6):1009-14. Epub 2008 Apr 15. 1909738
    View PubMed
  96. Gerber Y, Weston SA, Killian JM, Therneau TM, Jacobsen SJ, Roger VL. Neighborhood income and individual education: effect on survival after myocardial infarction. Mayo Clin Proc. 2008 Jun; 83(6):663-9. 1885155
    View PubMed
  97. Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD. Mortality attributable to cholestatic liver disease in the United States. Hepatology. 2008 Apr; 47(4):1241-7. 1904692
    View PubMed
  98. Gandy A, Therneau TM, Aalen OO. Global tests in the additive hazards regression model. Stat Med. 2008 Mar 15; 27(6):831-44. 1898800
    View PubMed
  99. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ 3rd. Serum aminotransferase activity and mortality risk in a United States community. Hepatology. 2008 Mar; 47(3):880-7. 1867802
    View PubMed
  100. Therneau TM. Memories of Sam Wieand. Lifetime Data Anal. 2008 Mar; 14(1):13-5. Epub 2007 Dec 12. 1883067
    View PubMed
  101. Dispenzieri A, Kyle RA, Katzmann JA, Therneau TM, Larson D, Benson J, Clark RJ, Melton LJ 3rd, Gertz MA, Kumar SK, Fonseca R, Jelinek DF, Rajkumar SV. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood. 2008 Jan 15; 111(2):785-9. Epub 2007 Oct 17. 1867670
    View PubMed
  102. Oberg AL, Mahoney DW, Eckel-Passow JE, Malone CJ, Wolfinger RD, Hill EG, Cooper LT, Onuma OK, Spiro C, Therneau TM, Bergen HR 3rd. Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res. 2008 Jan; 7(1):225-33. Epub 2008 Jan 04. 1966454
    View PubMed
  103. Therneau TM, Ballman KV. What does PLIER really do? Cancer Inform. 2008; 6:423-31. Epub 2008 Aug 27. 1929782
    View PubMed
  104. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum. 2007 Nov; 56(11):3583-7. 1853485
    View PubMed
  105. Gerber Y, Rihal CS, Sundt TM 3rd, Killian JM, Weston SA, Therneau TM, Roger VL. Coronary revascularization in the community. A population-based study, 1990 to 2004. J Am Coll Cardiol. 2007 Sep 25; 50(13):1223-9. Epub 2007 Sep 10. 1844421
    View PubMed
  106. Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, Plevak MF, Jelinek DF, Fonseca R, Melton LJ 3rd, Rajkumar SV. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007 Jun 21; 356(25):2582-90. 1824676
    View PubMed
  107. Vasmatzis G, Klee EW, Kube DM, Therneau TM, Kosari F. Quantitating tissue specificity of human genes to facilitate biomarker discovery. Bioinformatics. 2007 Jun 1; 23(11):1348-55. Epub 2007 Mar 23. 1828153
    View PubMed
  108. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, Talwalkar JA, Kim WR, Kamath PS. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007 Apr; 132(4):1261-9. 1818728
    View PubMed
  109. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007 Apr; 45(4):846-54. 1818658
    View PubMed
  110. Chen J, Yu K, Hsing A, Therneau TM. A partially linear tree-based regression model for assessing complex joint gene-gene and gene-environment effects. Genet Epidemiol. 2007 Apr; 31(3):238-51. 1833384
    View PubMed
  111. Crowson CS, Therneau TM, Matteson EL, Gabriel SE. Primer: Demystifying risk--understanding and communicating medical risks. Nat Clin Pract Rheumatol. 2007 Mar; 3(3):181-7; quiz 1 p following 187. 1810388
    View PubMed
  112. Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol. 2007 Mar; 5(3):394-402; quiz 267. 1815172
    View PubMed
  113. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2007 Mar; 56(3):820-30. 1815143
    View PubMed
  114. Mason CJ, Therneau TM, Eckel-Passow JE, Johnson KL, Oberg AL, Olson JE, Nair KS, Muddiman DC, Bergen HR 3rd. A method for automatically interpreting mass spectra of 18O-labeled isotopic clusters. Mol Cell Proteomics. 2007 Feb; 6(2):305-18. 1810457
    View PubMed
  115. Balan V, Aravind L, Grill DE, Therneau TM, Sulkowski MS, Nelson DR, Praestgaard J, Rosati M, Birse CE, Moore PA, Mani Subramanian G. Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C. Hepatol Res. 2006 Dec; 36(4):277-87. Epub 2006 Oct 09. 1834963
    View PubMed
  116. Eckel-Passow JE, Oberg AL, Therneau TM, Mason CJ, Mahoney DW, Johnson KL, Olson JE, Bergen HR 3rd. Regression analysis for comparing protein samples with 16O/18O stable-isotope labeled mass spectrometry. Bioinformatics. 2006 Nov 15; 22(22):2739-45. Epub 2006 Sep 05. 1792904
    View PubMed
  117. Oberg AL, Mahoney DW, Ballman KV, Therneau TM. Joint estimation of calibration and expression for high-density oligonucleotide arrays. Bioinformatics. 2006 Oct 1; 22(19):2381-7. Epub 2006 Jul 28. 1789316
    View PubMed
  118. Dingli D, Kyle RA, Rajkumar SV, Nowakowski GS, Larson DR, Bida JP, Gertz MA, Therneau TM, Melton LJ 3rd, Dispenzieri A, Katzmann JA. Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood. 2006 Sep 15; 108(6):1979-83. Epub 2006 Jun 01. 1782366
    View PubMed
  119. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006 May; 130(6):1652-60. 1762958
    View PubMed
  120. Ghobrial IM, Fonseca R, Gertz MA, Plevak MF, Larson DR, Therneau TM, Wolf RC, Hoffmann RJ, Lust JA, Witzig TE, Lacy MQ, Dispenzieri A, Vincent Rajkumar S, Zeldenrust SR, Greipp PR, Kyle RA. Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia. Br J Haematol. 2006 Apr; 133(2):158-64. 1968880
    View PubMed
  121. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006 Mar 30; 354(13):1362-9. 1754307
    View PubMed
  122. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology. 2006 Feb; 43(2):345-51. 1748394
    View PubMed
  123. Vachon CM, Sellers TA, Janney CA, Brandt KR, Carlson EE, Pankratz VS, Wu FF, Therneau TM, Cerhan JR. Alcohol intake in adolescence and mammographic density. Int J Cancer. 2005 Dec 10; 117(5):837-41. 1733761
    View PubMed
  124. Dewald GW, Therneau T, Larson D, Lee YK, Fink S, Smoley S, Paternoster S, Adeyinka A, Ketterling R, Van Dyke DL, Fonseca R, Kyle R. Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. Blood. 2005 Nov 15; 106(10):3553-8. Epub 2005 Jul 19. 1733872
    View PubMed
  125. Crowson CS, Nicola PJ, Maradit Kremers H, O'Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum. 2005 Oct; 52(10):3039-44. 1732202
    View PubMed
  126. Rajkumar SV, Kyle RA, Therneau TM, Melton LJ 3rd, Bradwell AR, Clark RJ, Larson DR, Plevak MF, Dispenzieri A, Katzmann JA. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood. 2005 Aug 1; 106(3):812-7. Epub 2005 Apr 26. 1726773
    View PubMed
  127. Rongey C, Bambha K, Vanness D, Pedersen RA, Malinchoc M, Therneau TM, Dickson ER, Kim WR. Employment and health insurance in long-term liver transplant recipients. Am J Transplant. 2005 Aug; 5(8):1901-8. 1729770
    View PubMed
  128. Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ 3rd. Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology. 2005 Aug; 129(2):486-93. 1724117
    View PubMed
  129. Palladini G, Kyle RA, Larson DR, Therneau TM, Merlini G, Gertz MA. Multicentre versus single centre approach to rare diseases: The model of systemic light chain amyloidosis. Amyloid. 2005 Jun; 12(2):120-6. 1729789
    View PubMed
  130. Eckel-Passow JE, Hoering A, Therneau TM, Ghobrial I. Experimental design and analysis of antibody microarrays: applying methods from cDNA arrays. Cancer Res. 2005 Apr 15; 65(8):2985-9. 1708096
    View PubMed
  131. Eckel JE, Gennings C, Therneau TM, Burgoon LD, Boverhof DR, Zacharewski TR. Normalization of two-channel microarray experiments: a semiparametric approach. Bioinformatics. 2005 Apr 1; 21(7):1078-83. Epub 2004 Oct 28. 1705097
    View PubMed
  132. Kyle RA, Rajkumar SV, Therneau TM, Larson DR, Plevak MF, Melton LJ 3rd. Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance. Clin Lymphoma. 2005 Mar; 5(4):257-60. 1714645
    View PubMed
  133. Pankratz VS, de Andrade M, Therneau TM. Random-effects Cox proportional hazards model: general variance components methods for time-to-event data. Genet Epidemiol. 2005 Feb; 28(2):97-109. 1694090
    View PubMed
  134. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ. Incidence of multiple myeloma in Olmsted County, Minnesota - Trend over 6 decades. Cancer. 2004 Dec 1; 101(11):2667-74. 1674459
    View PubMed
  135. Ballman KV, Grill DE, Oberg AL, Therneau TM. Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics. 2004 Nov 1; 20(16):2778-86. 1674074
    View PubMed
  136. Rajkumar SV, Kyle RA, Therneau TM, Clark RJ, Bradwell AR, Melton LJ, Larson DR, Plevak MF, Katzmann JA. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Br J Haematol. 2004 Nov; 127(3):308-10. 1669386
    View PubMed
  137. Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Rosen CB, Thostenson J, Benson JT, Dickson ER. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant. 2004 Nov; 4(11):1798-804. 1669391
    View PubMed
  138. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, Greipp PR, Witzig TE, Lust JA, Rajkumar SV, Fonseca R, Zeldenrust SR, McGregor CG, Jaffe AS. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004 Sep 15; 22(18):3751-7. 1665794
    View PubMed
  139. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, McConnell JP, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Hogan WJ, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust S Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2004 Sep 15; 104(6):1881-7. 1665799
    View PubMed
  140. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol. 2004 Sep; 99(9):1675-81. 1663586
    View PubMed
  141. Kim WR, Poterucha JJ, Benson JT, Therneau TM. The impact of competing risks on the observed rate of chronic hepatitis C progression. Gastroenterology. 2004 Sep; 127(3):749-55. 1665837
    View PubMed
  142. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ 3rd. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc. 2004 Jul; 79(7):859-66. 1653704
    View PubMed
  143. Kumar SK, Therneau TM, Gertz MA, Lacy MQ, Dispenzieri A, Rajkumar SV, Fonseca R, Witzig TE, Lust JA, Larson DR, Kyle RA, Greipp PR. Clinical course of patients with relapsed multiple myeloma. Mayo Clin Proc. 2004 Jul; 79(7):867-74. 1653705
    View PubMed
  144. Dispenzieri A, Kyle RA, Lacy MQ, Therneau TM, Larson DR, Plevak MF, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust SR, Snow DS, Hayman SR, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood. 2004 May 15; 103(10):3960-3. 1647045
    View PubMed
  145. Kim WR, Benson JT, Therneau TM, Torgerson HA, Yawn BP, Melton LJ. Changing epidemiology of hepatitis B in a US community. Hepatology. 2004 Mar; 39(3):811-6. 1641299
    View PubMed
  146. Baron TH, Harewood GC, Rumalla A, Pochron NL, Stadheim LM, Gores GJ, Therneau TM, De Groen PC, Sebo TJ, Salomao DR, Kipp BR. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol. 2004 Mar; 2(3):214-9. 1647217
    View PubMed
  147. Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood. 2003 Nov 15; 102(10):3759-64. Epub 2003 Jul 24. 1425070
    View PubMed
  148. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Yawn BP, Dickson ER, Melton LJ. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003 Nov; 125(5):1364-9. 1425147
    View PubMed
  149. Ghobrial IM, Dispenzieri A, Bundy KL, Gastineau DA, Rajkumar SV, Therneau TM, Lacy MQ, Witzig TE, Litzow MR, Christensen BR, Hayman S, Pribula CG, Gertz MA. Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma. Bone Marrow Transplant. 2003 Sep; 32(6):587-92. 1413616
    View PubMed
  150. Youdas JW, Krause DA, Egan KS, Therneau TM, Laskowski ER. The effect of static stretching of the calf muscle-tendon unit on active ankle dorsiflexion range of motion. Journal of Orthopaedic & Sports Physical Therapy. 2003 Jul; 33(7):408-17. 1422250
    View PubMed
  151. Dispenzieri A, Kyle RA, Gertz MA, Therneau TM, Miller WL, Chandrasekaran K, McConnell JP, Burritt MF, Jaffe AS. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet. 2003 May 24; 361(9371):1787-9. 1346819
    View PubMed
  152. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: definitions and long-term outcome. Blood. 2003 Apr 1; 101(7):2496-506. 1328731
    View PubMed
  153. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Semin Oncol. 2003 Apr; 30(2):169-71. 1341177
    View PubMed
  154. Therneau TM, Grambsch PM, Pankratz VS. Penalized survival models and frailty. Journal of Computational and Graphical Statistics. 2003 Mar; 12(1):156-75. 1325103
    View PubMed
  155. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003 Jan; 78(1):21-33. 1317936
    View PubMed
  156. Grabrick DM, Cerhan JR, Vierkant RA, Therneau TM, Cheville JC, Tindall DJ, Sellers TA. Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study. Cancer Detect Prev. 2003; 27(1):30-6. 1325157
    View PubMed
  157. Rajkumar SV, Kyle RA, Plevak MF, Murray JA, Therneau TM. Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. Br J Haematol. 2002 Dec; 119(3):706-8. 1317105
    View PubMed
  158. Therneau T, Tschumper RC, Jelinek D. Sharpening spots: correcting for bleedover in cDNA array images. Math Biosci. 2002 Mar; 176(1):1-15. 1315433
    View PubMed
  159. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton L. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002 Feb 21; 346(8):564-9. 1008213
    View PubMed
  160. Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Therneau TM, Kyle RA, Greipp PR, Gertz MA. Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation. Am J Hematol. 2001 Dec; 68(4):269-75. 1006969
    View PubMed
  161. Dispenzieri A, Lacy MQ, Kyle RA, Therneau TM, Larson DR, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Gertz MA. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol. 2001 Jul 15; 19(14):3350-6. 1005534
    View PubMed
  162. Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, Olson JE, Therneau TM, Folsom AR. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 2001 Jul; 12(4):420-8. 1314681
    View PubMed
  163. Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc. 2001 May; 76(5):476-87. 1004953
    View PubMed
  164. Steensma DP, Gertz MA, Greipp PR, Kyle RA, Lacy MQ, Lust JA, Offord JR, Plevak MF, Therneau TM, Witzig TE. A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death. Blood. 2001 Apr 15; 97(8):2522-3. 1004934
    View PubMed
  165. Couch FJ, Cerhan JR, Vierkant RA, Grabrick DM, Therneau TM, Pankratz VS, Hartmann LC, Olson JE, Vachon CM, Sellers TA. Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):327-32. 1004349
    View PubMed
  166. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb; 33(2):464-70. 1003492
    View PubMed
  167. Rumalla A, Baron TH, Leontovich O, Burgart LJ, Yacavone RF, Therneau TM, de Groen PC, Sebo TJ. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc. 2001 Jan; 76(1):29-33. 1003375
    View PubMed
  168. Kim WR, Lindor KD, Locke GR 3rd, Therneau TM, Homburger HA, Batts KP, Yawn BP, Petz JL, Melton LJ 3rd, Dickson ER. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000 Dec; 119(6):1631-6. 1013735
    View PubMed
  169. Figueiredo F, Dickson ER, Pasha T, Kasparova P, Therneau T, Malinchoc M, DiCecco S, Francisco-Ziller N, Charlton M. Impact of nutritional status on outcomes after liver transplantation. Transplantation. 2000 Nov 15; 70(9):1347-52. 140460
    View PubMed
  170. Kovtun IV, Therneau TM, McMurray CT. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene. Hum Mol Genet. 2000 Nov 1; 9(18):2767-75. 140428
    View PubMed
  171. Sorbi D, McGill DB, Thistle JL, Therneau TM, Henry J, Lindor KD. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am J Gastroenterol. 2000 Nov; 95(11):3206-10. 139945
    View PubMed
  172. Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Witzig TE, Lust JA, Larson D, Therneau TM, Kyle RA, Litzow MR, Greipp PR, Gertz MA. Effect of complete response on outcome following autologous stem cell transplantation for myeloma. Bone Marrow Transplant. 2000 Nov; 26(9):979-83. 139866
    View PubMed
  173. Angulo P, Patel T, Jorgensen RA, Therneau TM, Lindor KD. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology. 2000 Nov; 32(5):897-900. 139571
    View PubMed
  174. Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM, Olson JE, Couch FJ, Anderson KE, Pankratz VS, Sellers TA. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA. 2000 Oct 11; 284(14):1791-8. 1314584
    View PubMed
  175. Figueiredo FA, Dickson ER, Pasha TM, Porayko MK, Therneau TM, Malinchoc M, DiCecco SR, Francisco-Ziller NM, Kasparova P, Charlton MR. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl. 2000 Sep; 6(5):575-81. 137145
    View PubMed
  176. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Hepatopulmonary syndrome - a prospective study of relationships between severity of liver disease, PAO(2) response to 100% oxygen, and brain uptake after Tc-99m MAA lung scanning. Chest. 2000 Sep; 118(3):615-624. 137455
    View PubMed
  177. Brandhagen DJ, Gross JB Jr, Poterucha JJ, Germer JJ, Czaja AJ, Smith CI, Ribeiro AC, Guerrero RB, Therneau TM, Schiff E, Gordon FD, Wiesner RH, Persing DH. Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C. Am J Gastroenterol. 2000 Aug; 95(8):2056-60. 137126
    View PubMed
  178. Witzig TE, Meyers C, Therneau T, Greipp PR. A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders. Leuk Lymphoma. 2000 Jul; 38(3-4):345-50. 133180
    View PubMed
  179. Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, LaRusso NF, Lindor KD, Dickson ER. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc. 2000 Jul; 75(7):688-94. 135407
    View PubMed
  180. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA, Dickson ER. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl. 2000 Jul; 6(4):489-94. 136687
    View PubMed
  181. Youdas JW, Atwood AL, Harris-Love MO, Stiller TL, Egan KS, Therneau TM. Measurements of temporal aspects of gait obtained with a multimemory stopwatch in persons with gait impairments. J Orthop Sports Phys Ther. 2000 May; 30(5):279-86. 132679
    View PubMed
  182. Youdas JW, Garrett TR, Egan KS, Therneau TM. Lumbar lordosis and pelvic inclination in adults with chronic low back pain. Phys Ther. 2000 Mar; 80(3):261-75. 130253
    View PubMed
  183. Cleavinger PJ, Persing DH, Li H, Moore SB, Charlton MR, Sievers C, Therneau TM, Zein NN. Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol. 2000 Mar; 95(3):772-6. 130101
    View PubMed
  184. Kyle RA, Greipp PR, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Therneau TM. Waldenstrom's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil. Br J Haematol. 2000 Mar; 108(4):737-42. 133209
    View PubMed
  185. Brandhagen DJ, Alvarez W, Therneau TM, Kruckeberg KE, Thibodeau SN, Ludwig J, Porayko MK. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology. 2000 Feb; 31(2):456-60. 128314
    View PubMed
  186. Vierkant RA, Therneau TM, Kosanke JL, Naessens JM. MCSTRAT: A SAS Macro to analyze data from a matched or finely stratified case-control design. Technical Report Series Department of Health Sciences Research, Mayo Clinic, Rochester, MN. 2000(Number 65). 155816
  187. Sellers TA, King RA, Cerhan JR, Chen PL, Grabrick DM, Kushi LH, Oetting WS, Vierkant RA, Vachon CM, Couch FJ, Therneau TM, Olson JE, Pankratz VS, Hartmann LC, Anderson VE. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1051-7. 125958
    View PubMed
  188. Angulo P, Larson DR, Therneau TM, LaRusso NF, Batts KP, Lindor KD. Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol. 1999 Nov; 94(11):3310-3. 124316
    View PubMed
  189. Zein NN, Arslan M, Li H, Charlton MR, Gross JB Jr, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH. Clinical significance of TT virus infection in patients with chronic hepatitis C. Am J Gastroenterol. 1999 Oct; 94(10):3020-7. 1009293
    View PubMed
  190. Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma. Bone Marrow Transplant. 1999 Sep; 24(5):497-503. 1009024
    View PubMed
  191. Sabers SR, Kokal JE, Girardi JC, Philpott CL, Basford JR, Therneau TM, Schmidt KD, Gamble GL. Evaluation of consultation-based rehabilitation for hospitalized cancer patients with functional impairment. Mayo Clin Proc. 1999 Sep; 74(9):855-61. 1008999
    View PubMed
  192. Winemiller MH, Stolp-Smith KA, Silverstein MD, Therneau TM. Prevention of venous thromboembolism in patients with spinal cord injury: effects of sequential pneumatic compression and heparin. J Spinal Cord Med. 1999 Fall; 22(3):182-91. 130315
    View PubMed
  193. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Malinchoc M, Benson JT, Crippin JS, Klintmalm GB, Rakela J, Starzl TE, Krom RA, Evans RW, Dickson ER. Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization. Hepatology. 1999 Aug; 30(2):395-400. 1008809
    View PubMed
  194. Ansell SM, Kurtin PJ, Stenson M, Habermann TM, Greipp PR, Therneau TM, Witzig TE. Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index. Leuk Lymphoma. 1999 Aug; 34(5-6):529-37. 1009100
    View PubMed
  195. Rajkumar SV, Fonseca R, Dewald GW, Therneau TM, Lacy MQ, Kyle RA, Greipp PR, Gertz MA. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma. Cancer Genet Cytogenet. 1999 Aug; 113(1):73-7. 1008954
    View PubMed
  196. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma. Bone Marrow Transplant. 1999 Jun; 23(12):1261-1266. 117647
    View PubMed
  197. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Autologous stem cell transplantation for relapsed and primary refractory myeloma. Bone Marrow Transplant. 1999 Jun; 23(12):1267-72. 117648
    View PubMed
  198. Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, Therneau TM, Malinchoc M, Dickson ER. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology. 1999 Jun; 29(6):1643-8. 115581
    View PubMed
  199. Therneau TM, Li H. Computing the Cox model for case cohort designs. Lifetime Data Anal. 1999 Jun; 5(2):99-112. 1009281
    View PubMed
  200. Georgiopoulos AM, Bryan TL, Yawn BP, Houston MS, Rummans TA, Therneau TM. Population-based screening for postpartum depression. Obstet Gynecol. 1999 May; 93(5 Pt 1):653-7. 115089
    View PubMed
  201. Angulo P, Dickson ER, Therneau TM, Jorgensen RA, Smith C, DeSotel CK, Lange SM, Anderson ML, Mahoney DW, Lindor KD. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. J Hepatol. 1999 May; 30(5):830-5. 115138
    View PubMed
  202. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA, Litzow MR, Gertz MA, Greipp PR. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. J Clin Oncol. 1999 May; 17(5):1551-7. 115286
    View PubMed
  203. Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology. 1999 May; 29(5):1396-8. 115066
    View PubMed
  204. Angulo P, Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Kamath PS, Dickson ER. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver. 1999 Apr; 19(2):115-21. 109986
    View PubMed
  205. Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology. 1999 Mar; 29(3):644-7. 109695
    View PubMed
  206. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood. 1999 Feb 1; 93(3):1062-6. 109271
    View PubMed
  207. Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, Crippin JS, Klintmalm GB, Levy MF, Ricci P, Therneau TM, Dickson ER. Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology. 1999 Feb; 29(2):356-64. 109259
    View PubMed
  208. Pasha T, Heathcote J, Gabriel S, Cauch-Dudek K, Jorgensen R, Therneau T, Dickson ER, Lindor KD. Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis. Hepatology. 1999 Jan; 29(1):21-6. 108967
    View PubMed
  209. Witzig TE, Timm M, Larson D, Therneau T, Greipp PR. Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders. Br J Haematol. 1999 Jan; 104(1):131-7. 109404
    View PubMed
  210. Vierkant RA, Therneau TM, Kosanke JL, Naessens JM. A SAS macro to analyze data from a matched or timely stratfied case-control design. Proc 24th Ann SAS Users Group Inter. 1999:1650-5. 155665
  211. Fonseca R, Ahmann GJ, Jalal SM, Dewald GW, Larson DR, Therneau TM, Gertz MA, Kyle RA, Greipp PR. Chromosomal abnormalities in systemic amyloidosis. Br J Haematol. 1998 Dec; 103(3):704-10. 108843
    View PubMed
  212. Angulo P, Therneau TM, Jorgensen A, DeSotel CK, Egan KS, Dickson ER, Hay JE, Lindor KD. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol. 1998 Nov; 29(5):729-35. 108573
    View PubMed
  213. Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK. Increased risk of chronic liver failure in adults with heterozygous alpha (1)-antitrypsin deficiency. Hepatology. 1998 Oct; 28(4):1058-1063. 107966
    View PubMed
  214. Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, Krom R, Wiesner R. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology. 1998 Sep; 28(3):839-42. 107672
    View PubMed
  215. Witzig TE, Kimlinger T, Stenson M, Therneau T. Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia. Leuk Lymphoma. 1998 Sep; 31(1-2):167-75. 107484
    View PubMed
  216. Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB, Crippin JS, Krom RA, Dickson ER. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology. 1998 Jul; 28(1):33-8. 106198
    View PubMed
  217. Pasha T, Gabriel S, Therneau T, Dickson ER, Lindor KD. Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology. 1998 May; 27(5):1220-6. 104904
    View PubMed
  218. Melton LJ, Therneau TM, Larson DR. Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int. 1998; 8(1):68-74. 103924
    View PubMed
  219. Lindor KD, Jorgensen RA, Therneau TM, Malinchoc M, Dickson ER. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clin Proc. 1997 Dec; 72(12):1137-40. 100706
    View PubMed
  220. Kim WR, Poterucha JJ, Hermans JE, Therneau TM, Dickson ER, Evans RW, Gross JB Jr. Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Ann Intern Med. 1997 Nov 15; 127(10):866-74. 100939
    View PubMed
  221. Therneau TM, Hamilton SA. rhDNase as an example of recurrent event analysis. Stat Med. 1997 Sep 30; 16(18):2029-47. 100007
    View PubMed
  222. van Dam GM, Verbaan BW, Therneau TM, Dickson ER, Malinchoc M, Murtaugh PA, Huizenga JR, Gips CH. Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation. Hepatogastroenterology. 1997 May-Jun; 44(15):732-43. 99122
    View PubMed
  223. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med. 1997 Apr 24; 336(17):1202-7. 102233
    View PubMed
  224. Ricci P, Therneau TM, Malinchoc M, Benson JT, Petz JL, Klintmalm GB, Crippin JS, Wiesner RH, Steers JL, Rakela J, Starzl TE, Dickson ER. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology. 1997 Mar; 25(3):672-7. 101891
    View PubMed
  225. Van Norstrand MD, Malinchoc M, Lindor KD, Therneau TM, Gershwin ME, Leung PS, Dickson ER, Homburger HA. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology. 1997 Jan; 25(1):6-11. 101530
    View PubMed
  226. Therneau TM. Extending the Cox model. Proceedings of the First Seattle Symposium in Eds Lin DY and Felming, TR Springer-Verlag, New York, 51-84, 1997; Biostatistics:Survival Analysis. 142275
  227. Nativ O, Umehara T, Colvard DS, Therneau TM, Farrow GM, Spelsberg TC, Lieber MM. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer. Eur Urol. 1997; 32(1):96-9. 99345
    View PubMed
  228. Huang MS, Colby TV, Therneau TM, Daly RC, Gonchoroff NJ. DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry. Cytometry. 1996 Dec 15; 26(4):253-9. 98385
    View PubMed
  229. Zein NN, Poterucha JJ, Gross JB Jr, Wiesner RH, Therneau TM, Gossard AA, Wendt NK, Mitchell PS, Germer JJ, Persing DH. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am J Gastroenterol. 1996 Dec; 91(12):2560-2. 98344
    View PubMed
  230. Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood. 1996 Jul 1; 88(1):289-96. 96652
    View PubMed
  231. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology. 1996 May; 110(5):1515-8. 96102
    View PubMed
  232. Ludwig J, Hashimoto E, Porayko MK, Therneau TM. Failed allografts and causes of death after orthotopic liver transplantation from 1985 to 1995: decreasing prevalence of irreversible hepatic allograft rejection. Liver Transplantation & Surgery. 1996 May; 2(3):185-91. 97220
    View PubMed
  233. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 1996 Mar; 110(3):848-57. 95430
    View PubMed
  234. Locke GR 3rd, Therneau TM, Ludwig J, Dickson ER, Lindor KD. Time course of histological progression in primary biliary cirrhosis. Hepatology. 1996 Jan; 23(1):52-6. 103693
    View PubMed
  235. Grambsch PM, Therneau TM, Fleming TR. Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics. 1995 Dec; 51(4):1469-82. 91038
    View PubMed
  236. Kim WR, Therneau TM, Dickson ER, Evans RW. Preoperative predictors of resource utilization in liver transplantation. Clin Transpl. 1995; 315-22. 94668
  237. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994 Sep; 81:515-526. 90110
  238. Nativ O, Winkler HZ, Farrow GM, Therneau TM, Lieber MM. Clinical significance of nuclear DNA ploidy pattern in nonseminomatous germ cell testicular tumors. Urology. 1994 Feb; 43(2):197-202. 87010
    View PubMed
  239. Therneau TM. How many stratification factors are "too many" to use in a randomization plan? Control Clin Trials. 1993 Apr; 14(2):98-108. 83683
    View PubMed
  240. Oakes D, Moss AJ, Fleiss JL, Bigger JT Jr, Therneau TM, Eberly SW, McDermott MP, et al. Use of compliance measured in an analysis of the effect of diltiazem on mortality and reinfarction after myocardial infarction. J Amer Stat Assoc. 1993; 88:44-9. 142274
  241. Laurie J, Hahn R, Therneau T, Patel S, Mailliard J, Windschitl H, Twito D, Morton R, Krook J Chemotherapy for hormonally refractory advanced prostate carcinoma: A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil Cancer. 1992; 69:1440-1444. 2003071
    View PubMed
  242. Laurie JA, Hahn RG, Therneau TM, Patel SR, Mailliard JA, Windschitl HE, Twito DI, Morton RF, Krook JE. Chermotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil. Cancer. 1992; 69:1440-4. 142273
    View PubMed
  243. Bajzer Z, Therneau TM, Sharp JC, Prendergast FG. Maximum likelihood method for the analysis of time-resolved fluorescence decay curves. Eur Biophys J. 1991 Dec; 20:247-262. 77784
  244. Morton RF, Jett JR, McGinnis WL, Earle JD, Therneau TM, Krook JE, Elliott TE, Mailliard JA, Nelimark RA, Maksymiuk AW, et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med. 1991 Nov 1; 115(9):681-6. 75544
    View PubMed
  245. Witzig TE, Gonchoroff NJ, Therneau T, Gilbertson DT, Wold LE, Grant C, Grande J, Katzmann JA, Ahmann DL, Ingle JN. DNA content flow cytometry as a prognostic factor for node-positive breast cancer: the role of multiparameter ploidy analysis and specimen sonication. Cancer. 1991 Oct 15;68(8):1781-8. 1037921
  246. Long HJ, Hauge MD, Therneau TM, Buckner JC, Frytak S, Hahn RG. Phase II evaluation of menogaril in patients with advanced hypernephroma. Invest New Drugs. 1991 Aug; 9(3):261-2. 142272
    View PubMed
  247. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL, Goldberg R. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol. 1991 Mar; 9(3):449-52. 1036681
    View PubMed
  248. Morton R, Jett J, McGinnis W, Earle J, Therneau T, Krook J, Elliott T, Mailliard J, Nelimark R, Maksymiuk A, Drummond R, Laurie J, Kugler J, Anderson R Randomized phase III trial of thoracic radiation therapy alone versus combined chemoradiotherapy for locally unresectable non-small cell lung cancer Ann Intern Med. 1991; 115:681-686. 2003068
    View PubMed
  249. Goldberg RM, Jett JR, Therneau TM, Johnson PS, Tschetter LK, Krook JE, Veeder MH, Owen D, Etzell PS, Andres DF. Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group. J Natl Cancer Inst. 1990 Dec 19; 82(24):1899-903. 71804
    View PubMed
  250. Tefferi A, Zellers RA, Banks PM, Therneau TM, Colgan JP. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease. J Clin Oncol. 1990 Dec; 8(12):1959-65. 74494
    View PubMed
  251. Patel SR, Kvols LK, Hahn RG, Windschitl H, Levitt R, Therneau T. A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. Cancer. 1990 Aug 15; 66(4):655-8. 73368
    View PubMed
  252. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990 Aug; 8(8):1327-34. 74962
    View PubMed
  253. Nativ O, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma. J Urol. 1990 Aug; 144(2 Pt 1):303-6. 73191
    View PubMed
  254. Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham NL, Therneau TM, Hagen L, Gainey DK, Cross M, Athmann LM. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer. 1990 Apr 15; 65(8):1879-82. 1034226
    View PubMed
  255. Montgomery BT, Nativ O, Blute ML, Farrow GM, Myers RP, Zincke H, Therneau TM, Lieber MM. Stage three prostate adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Arch Surg. 1990 Mar; 125:327-331. 72194
    View PubMed
  256. Jett JR, Everson L, Therneau TM, Krook JE, Dalton RJ, Marschke RF Jr, Veeder MH, Brunk SF, Mailliard JA, Twito DI, et al. Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group. J Clin Oncol. 1990 Jan; 8(1):33-8. 2106849
    View PubMed
  257. Schaid DJ, Wieand HS, Therneau TM. Optimal two-stage screening designs for survival comparisons. Biometrika. 1990; 77(3):507-13. 141622
  258. Therneau TM, Wieand HS, Chang MN. Optimal designs for a grouped sequential binomial trial. Biometrics. 1990; 46:771-81. 142266
  259. Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals for survival models. Biometrika. 1990; 77(1):147-60. 142267
  260. Grambsch PM, Kosanke JL, Therneau TM, Schaid DJ, Zinsmeister AR, Wieand HS, Offord KP, LarsonKeller JJ. The GLIM procedure: An interface to the SAS system. Proc 15th Annual SAS Users Group International Converence Cary SAS Institute, Inc. 1990. 142301
  261. Goldberg R, Jett J, Therneau T, Johnson P, Tschetter L, Krook J, Veeder M, Owen D, Etzell P, Andres D Bolus versus infusional etoposide and cisplatinum in treatment of non-small cell lung cancer: A study of the North Central Cancer Treatment Group J Natl Cancer Inst. 1990; 82:1899-1903. 2003054
    View PubMed
  262. Patel S, Kvols L, Hahn R, Windschitl H, Levitt R, Therneau T A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate Cancer. 1990; 66:655-658. 2003055
    View PubMed
  263. Blute ML, Nativ O, Zincke H, Farrow GM, Therneau T, Lieber MM. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. J Urol. 1989 Nov; 142(5):1262-5. 70183
    View PubMed
  264. Tefferi A, Hoagland HC, Therneau TM, Pierre RV. Chronic myelomonocytic leukemia: natural history and prognostic determinants. Mayo Clin Proc. 1989 Oct; 64(10):1246-54. 70232
    View PubMed
  265. Nativ O, Winkler HZ, Raz Y, Therneau TM, Farrow GM, Myers RP, Zincke H, Lieber MM. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Mayo Clin Proc. 1989 Aug; 64(8):911-9. 69813
    View PubMed
  266. Witzig TE, Gonchoroff NJ, Greipp PR, Katzmann JA, Stenson MJ, Habermann TM, Colgan JP, Therneau TM, Banks PM. Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure. Am J Clin Pathol. 1989 Mar; 91(3):298-301. 68757
    View PubMed
  267. Therneau TM, Solberg LA Jr, Jenkins RB. Modeling megakaryocyte development as a branching process. Comput Math Appl. 1989; 18:959-964. 70681
  268. Loprinzi CL, Love RR, Therneau TM, Verman AK. Inhibition of human skin ornithine decarboxylase activity by oral alpha-diflouromethylornithine. Cancer Therapy and Control. 1989; 1:75-80. 71258
  269. Letendre L, Niedringhaus RD, Therneau TM, Gastineau DA, Goldberg RM, Gerstner JB, Mailliard JA, Gundlach WJ, Kardinal CG, Pierre RV. Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside. Med Pediatr Oncol. 1989; 17(2):79-82. 69088
    View PubMed
  270. Blute ML, Tsushima K, Farrow GM, Therneau TM, Lieber MM. Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry. J Urol. 1988 Nov; 140(5):944-9. 66727
    View PubMed
  271. Witzig TE, Gonchoroff NJ, Katzmann JA, Therneau TM, Kyle RA, Greipp PR. Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J Clin Oncol. 1988 Jun; 6(6):1041-6. 65522
    View PubMed
  272. Winkler HZ, Rainwater LM, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clin Proc. 1988 Feb; 63(2):103-12. 64673
    View PubMed
  273. Eagan RT, Frytak S, Richardson RL, Creagan ET, Therneau TM, Coles DT, Jett JR. A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer. J Clin Oncol. 1988 Jan; 6(1):5-8. 64659
    View PubMed
  274. Myers RP, Therneau TM, Zincke H, Utz DC. Radical prostatectomy and the influence of early endocrine therpay for stage D1 prostate cancer: long-term follow-up study. A multidisciplining analysis of contraoversies in the management of prostate cancer pg 183-194 Plenum, New York, 1988. 142265
  275. Tibbits PA, Evaul JE, Goldstein RE, Boccuzzi SJ, Therneau TM, Parker R, Wong D. Serial acquisition of data to predict one-year mortality rate after acute myocardial infarction. Am J Cardiol 1 1987 Sept; 60:451-5. 142262
  276. Buck M, Ingle JN, Giuliani ER, Gordon JR, Therneau TM. Pericardial effusion in women with breast cancer. Cancer. 1987 Jul 15; 60(2):263-9. 62431
    View PubMed
  277. Eagan RT, Frytak S, Lee RE, Therneau TM, Richardson RL, Creagan ET. No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer. Am J Clin Oncol. 1987 Apr; 10(2):141-5. 61587
    View PubMed
  278. Eagan RT, Therneau TM, Rubin J, Long HJ, Schutt AJ. Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial. Am J Clin Oncol. 1987 Feb; 10(1):82-5. 61253
    View PubMed
  279. Chang MN, Therneau TM, Wieand HS, Cha SS. Designs for group sequential phase II clinical trials. Biometrics. 1987; 43:865-74. 157086
    View PubMed
  280. Moss AJ, Bigger T, Carleen E, Fleiss JL, Odoroff CL, Rolnitecky LR, Therneau TM. The mortality risk associated with digitalis treatment after myocardial infarction. Cardiovasc Drugs and Therapy. 1987; 1:125-32. 142263
  281. Wieand HS, Therneau TM. A two-stage design for randomized trials with binary outcome. Controlled Clin Trials 1987 1987; 8:20-8. 142261
  282. Mailliard JA, Letendre L, Dalton RJ, Levitt R, Gerstner JB, Therneau TM, Pierre RV. Phase I-II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia. Med Pediatr Oncol. 1986; 14(6):306-9. 59551
    View PubMed